Memantine, an antagonist of the NMDA glutamate receptor, breaks down at a much slower rate than acetylcholinesterase (AChE) inhibitors, such as donepezil aricept, which is often used to treat the symptoms of AD [35,36]. The gene discussed is ACHE; the disease is Alzheimer disease.